Anemia secondary to valproic acid therapy in a 13-year-old boy: A case report

Journal of Medical Case Reports

Volumn 6, Issue , 2012, Pages

  Kaczorowska Hac, Barbara ^a   Matheisel, Agnieszka ^a   MacIejka Kapuscinska, Lucyna ^a   Wisniewski, Jakub ^a   Alska, Anna ^a   Adamkiewicz Drozynska, Elzbieta ^a   Balcerska, Anna ^a   Reszczynska, Iwona ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Anemia; Child; Valproic acid

Indexed keywords

VALPROIC ACID;

ADOLESCENT; ANEMIA; APLASTIC ANEMIA; ARTICLE; BLOOD TOXICITY; BONE MARROW BIOPSY; BONE MARROW TOXICITY; CASE REPORT; CELL CYCLE ARREST; CONVALESCENCE; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; DYSERYTHROPOIESIS; EPILEPSY; ERYTHROBLAST; ERYTHROCYTE COUNT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; LEUKOPENIA; MACROCYTIC ANEMIA; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEGALOCYTOSIS; PRIORITY JOURNAL; PROERYTHROBLAST; PROGNOSIS; PURE RED CELL ANEMIA; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL;

EID: 84867400148     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-6-239     Document Type: Article

References (13)

1. Pure red cell aplasia after 13years of sodium valproate, and bone marrow suppression after 17years of carbamazepine. The T, Kolla R, Dawkins F, Trouth AJ, PLoS Med 2004 1 51 10.1371/journal.pmed.0010051 15578114
2. Idiosyncratic adverse reactions to antiepileptic drugs. Zaccara G, Franciotta D, Perucca E, Epilepsia 2007 48 1223 1244 10.1111/j.1528-1167.2007. 01041.x 17386054
3. Hematologic toxicity of sodium valproate. Acharya S, Bussel JB, J Pediatr Hematol Oncol 2000 22 62 65 10.1097/00043426-200001000-00012 10695824
4. Risk of aplastic anemia in patients using antiepileptic drugs. Handoko KB, Souverein PC, van Staa TP, Meyboom RH, Leufkens HG, Egberts TC, van den Bemt PM, Epilepsia 2006 47 1232 1236 10.1111/j.1528-1167.2006.00596.x 16886988
5. Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia] [in Japanese. Kanada J, Chonabayashi K, Watanabe M, Arima N, Tsudo M, Rinsho Ketsueki 2005 46 1114 1117 16440773
6. Temporary pure red-cell aplasia during valproate monotherapy: clinical observations and spectral electroencephalographic aspects. Farkas V, Szabá M, Rényi I, Kohlhéb O, Benninger C, J Child Neurol 2000 15 485 487 10.1177/088307380001500713 10921523
7. Valproate-induced thrombocytopenia: a prospective monotherapy study. Nasreddine W, Beydoun A, Epilepsia 2008 49 438 445 10.1111/j.1528-1167.2007. 01429.x 18031547
8. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents. Rahman A, Mican LM, Fischer C, Campbell AH, Ann Pharmacother 2009 43 822 830 10.1345/aph.1L617 19401471
9. Pancytopenia in the course of acute valproic acid poisoning: case report [in Polish]. Klimaszyk D, ukasik-Gebocka M, Przegl Lek 2011 68 539 542 22010461
10. The effect of carbamazepine and sodium valproate on the blood and serum values of children from a Third-World environment. Hemingway C, Leary M, Riordan G, Schlegal G, Walker K, J Child Neurol 1999 14 751 753 10.1177/ 088307389901401114 10593556
11. Severe anemia secondary to a probable drug interaction between zidovudine and valproic acid. Antoniou T, Gough K, Yoong D, Arbess G, Clin Infect Dis 2004 38 38 e40 10.1086/381760 14986271
12. Valproate-induced pure red cell aplasia and megakaryocyte dysplasia. Bartakke S, Abdelhaleem M, Carcao M, Br J Haematol 2008 141 133 10.1111/j.1365-2141.2008.06979.x 18353161
13. Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway. Chateauvieux S, Eifes S, Morceau F, Grigorakaki C, Schnekenburger M, Henry E, Dicato M, Diederich M, Biochem Pharmacol 2011 81 498 509 10.1016/j.bcp.2010.11. 011 21108933